Tech Stake Shifts and Mega Deals Lead Market Buzz; Focus on Meesho, Lenskart Amid FDA Scrutiny

Tech Stake Shifts and Mega Deals Lead Market Buzz; Focus on Meesho, Lenskart Amid FDA Scrutiny​

The financial markets are buzzing with major block deals, regulatory inspections in the pharma sector, and significant infrastructure wins across various industries. Investors are keenly tracking stake sales by venture capital firms as pharmaceutical companies undergo routine scrutiny from global health agencies. This dynamic blend of investor movements and corporate milestones makes several stocks key focus areas for today’s trade.

Key Stake Shifts and Block Deals​

Venture capitalists (VCs) and investment funds are actively engaging in block trades involving promising startups. Y Combinator is likely to sell up to a 1.05 percent stake in Meesho via a block deal, with the deal sized at estimated Rs 957.5 crore and set at a floor price of Rs 197.5 per share, according to reports.

Similarly, SoftBank Vision Fund (SVF) II Lightbulb Cayman is likely to sell up to a 2.6 percent stake in Lenskart Solutions through block deals. The offer size for this transaction stands at approximately $300 million, with the floor price set at Rs 635 per share.

In financial news, Bank of Baroda has concluded the issuance of an additional $400 million of senior unsecured Reg-S fixed-rate notes. This issuance is through its IFSC Banking Unit (IFSCBU) and will be listed on the Singapore Exchange and GIFT City markets.

Pharmaceutical Sector Under FDA Spotlight​

The pharmaceutical industry remains under close scrutiny following inspections conducted by the United States Food and Drug Administration (US FDA). Caplin Point Laboratories received a Form 483 with 10 procedural observations after its inspection at its sterile manufacturing facility in Gummidipoondi. None of these observations were repeat findings.

Natco Pharma also faced an FDA inspection, resulting in four procedural observations being issued via a Form 483 following the review of their Finished Dosage Formulations (FDF) plant. Meanwhile, Choksi Laboratories was given four observations after its central laboratory inspection in Indore. Aurobindo Pharma’s routine inspection concluded with only one observation related to facility and equipment maintenance.

Corporate Wins and Infrastructure Boost​

NTPC Green Energy secured a massive contract through an e-reverse auction conducted by SECI. NTPC Renewable Energy, the wholly owned subsidiary of the company, successfully bid for 500 MW of renewable energy capacity at a discovered tariff of Rs 6.00/kWh.

Craftsman Automation is moving forward with strategic international expansion. The Board has approved a proposal to incorporate Craftsman Fronberg Precision GmbH in Germany through its existing subsidiary. Furthermore, Zee Entertainment Enterprises allotted 20.94 crore convertible warrants to Sunbright Mauritius for Rs 659.76 crore upfront.

Shree Renuka Sugars saw ICICI Bank reduce its stake from 8.96 percent to 6.79 percent after selling a 2.17 percent shareholding in multiple tranches. In corporate development, Craftsman Automation is integrating the German market through this acquisition.

Investor Activity and Quarterly Earnings Review​

The bulk deal market saw significant movement in several key stocks. Accel, along with Trudy Holdings and AVP I Fund, sold a 4.84 percent stake in Amagi Media Labs for Rs 587.3 crore at a price of Rs 560 per share. Qualcomm Asia Pacific Pte also reduced its holding by selling 1.28 percent of Shadowfax Technologies at Rs 245.13 apiece, valuing the transaction at Rs 183.8 crore.

Regarding earnings, Heranba Industries reported that its profit grew 17% to Rs 7.14 crore compared to Rs 6.1 crore in Q1 (consolidated YoY). However, revenue saw a decline of 15.3%, falling to Rs 383.2 crore from Rs 452.4 crore.

In the REIT sector, Nxt-Infra Trust witnessed active unit trading as Kotak Mahindra Bank and Larsen & Toubro acquired units. Simultaneously, Actis Highway Infra sold 64.5 lakh units in Nxt-Infra Trust for Rs 60.9 crore at a price of Rs 94.40 per unit.